COMMUNIQUÉS West-GlobeNewswire

FDA Advisory Committee Votes in Favor of WAYLIVRA for Treatment of Familial Chylomicronemia Syndrome
11/05/2018
Advisory Committee members vote 12-8 to support approval CAMBRIDGE, Mass. and CARLSBAD, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA ), an affiliate of Ionis Pharmaceuticals, Inc., and [...]
Coherus BioSciences Reports Corporate Highlights and First Quarter 2018 Financial Results
10/05/2018
REDWOOD CITY, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS ), today reviewed corporate highlights and reported financial results for the quarter ended March 31, 2018. First Quarter [...]
Jamieson Wellness Inc. Announces Voting Results from 2018 Annual Meeting of Shareholders
11/05/2018
TORONTO, May 10, 2018 (GLOBE NEWSWIRE) -- Jamieson Wellness Inc. (“ Jamieson Wellness ” or the “ Company ”) (TSX: JWEL ) announced today that each of the nominee directors listed in the management information circular [...]
Adamis Pharmaceuticals Announces First Quarter 2018 Financial Results and Business Update
10/05/2018
SAN DIEGO, May 10, 2018 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP ) today announced financial results and a business update for the first quarter ended March 31, 2018. Dr. Dennis J. Carlo, [...]
Carrie Arran Resources Inc. and Fleurish Cannabis Inc. Announce Extension of Definitive Agreement Relating to Reverse Takeover Transaction
10/05/2018
TORONTO, May 10, 2018 (GLOBE NEWSWIRE) -- Carrie Arran Resources Inc. ("Carrie Arran") announces that it has extended the expiry date of the definitive agreement with Fleurish Cannabis Inc. ("Fleurish Cannabis") ( [...]
Sienna Senior Living Inc. Reports 2018 First Quarter Financial Results
10/05/2018
MARKHAM, Ontario, May 10, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA ) today announced its financial results for the three months ended March 31, 2018. The Unaudited [...]
Aclaris Therapeutics to Attend Upcoming Investor Conferences
10/05/2018
WAYNE, Pa., May 10, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), a dermatologist-led biopharmaceutical company committed to identifying, developing, and commercializing innovative therapies to [...]
Extendicare Announces 2018 First Quarter Results
10/05/2018
MARKHAM, Ontario, May 10, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) today reported results for the three months ended March 31, 2018. Results are presented in Canadian [...]
Emergent BioSolutions to Hold Annual Meeting of Stockholders on Thursday, May 24, 2018 at 9:00 AM EDT; Webcast Will Be Available
10/05/2018
GAITHERSBURG, Md., May 10, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS ) has announced that it will hold its Annual Meeting of Stockholders on Thursday, May 24, 2018 beginning at 9:00 AM EDT at the [...]
La Jolla Pharmaceutical Company Announces $125 Million Royalty Financing Agreement with HealthCare Royalty Partners
10/05/2018
SAN DIEGO, May 10, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC ) (La Jolla), a leader in the discovery, development and commercialization of innovative therapies intended to significantly [...]
La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2018 and Recent Corporate Progress
10/05/2018
SAN DIEGO, May 10, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC ), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve [...]
Medtronic to Announce Financial Results for Its Fourth Quarter and Fiscal Year 2018
10/05/2018
DUBLIN - May 10, 2018 - Medtronic plc (NYSE: MDT) announced today that it will report financial results for its fourth quarter and fiscal year 2018 on Thursday, May 24, 2018. A news release will be issued at [...]
Checkpoint Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights
10/05/2018
NEW YORK, May 10, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT ), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]
Dyadic International Reports First Quarter 2018 Financial Results
10/05/2018
Three new research collaborations Positive results in our initial glycoengineering modifications of C1 strains Achieving high levels of productivity for therapeutic proteins Board approved a reverse stock split subject [...]
MyoKardia to Present at the Bank of America Merrill Lynch 2018 Health Care Conference
10/05/2018
SOUTH SAN FRANCISCO, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK ), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable [...]
Kane Biotech Schedules First Quarter 2018 Earnings Conference Call and Business Update
10/05/2018
Conference call to take place Friday, May 18, 2018 at 8:30am E.T. WINNIPEG, Manitoba, May 10, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE ), (OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) is pleased to [...]
Cytori Reports Q1 2018 Business and Financial Results
10/05/2018
SAN DIEGO, May 10, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics (NASDAQ: CYTX ) (“Cytori” or the “Company”) today announced Q1 2018 financial results and provided updates on corporate development. Q1 2018 net loss was $ [...]
Fortress Biotech Reports First Quarter 2018 Financial Results and Recent Corporate Highlights
10/05/2018
NEW YORK, May 10, 2018 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO ) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology [...]
Globus Medical Announces Corporate Alliance Partnership with the Society of Lateral Access Surgery
10/05/2018
AUDUBON, Pa., May 10, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED ), a leading musculoskeletal solutions company, announced today it is sponsoring the Society of Lateral Access Surgery’s (SOLAS®) newly [...]

Pages